Nanometrics Inc. (NASDAQ:NANO) has received a consensus rating of “Hold” from the five brokerages that are currently covering the company. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is $21.33.
Several research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Nanometrics from a “hold” rating to a “sell” rating in a report on Tuesday, September 27th. Stifel Nicolaus upped their target price on shares of Nanometrics from $21.00 to $25.00 and gave the company a “buy” rating in a report on Monday, June 27th.
Shares of Nanometrics (NASDAQ:NANO) traded down 5.680% on Wednesday, hitting $20.175. 183,236 shares of the company traded hands. The company has a market capitalization of $500.18 million, a PE ratio of 58.819 and a beta of 1.46. Nanometrics has a 12 month low of $12.50 and a 12 month high of $23.61. The stock’s 50-day moving average price is $21.37 and its 200-day moving average price is $19.32.
Nanometrics (NASDAQ:NANO) last posted its quarterly earnings results on Tuesday, July 26th. The company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.27 by $0.01. Nanometrics had a return on equity of 6.06% and a net margin of 4.44%. The firm had revenue of $55.80 million for the quarter, compared to analyst estimates of $55.30 million. During the same quarter last year, the firm earned $0.08 EPS. The company’s revenue was up 14.8% on a year-over-year basis. On average, equities analysts predict that Nanometrics will post $0.99 earnings per share for the current year.
In related news, Director Bruce C. Rhine sold 10,000 shares of the stock in a transaction on Monday, October 3rd. The shares were sold at an average price of $22.08, for a total transaction of $220,800.00. Following the completion of the sale, the director now owns 794,108 shares in the company, valued at approximately $17,533,904.64. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Stanislaw M. Borowicz sold 1,630 shares of the stock in a transaction on Thursday, September 22nd. The stock was sold at an average price of $21.98, for a total transaction of $35,827.40. Following the sale, the vice president now owns 44,433 shares of the company’s stock, valued at approximately $976,637.34. The disclosure for this sale can be found here. Corporate insiders own 5.80% of the company’s stock.
A number of hedge funds have recently modified their holdings of the company. Royce & Associates LP boosted its stake in shares of Nanometrics by 6.2% in the first quarter. Royce & Associates LP now owns 2,807,174 shares of the company’s stock worth $44,466,000 after buying an additional 162,908 shares in the last quarter. BlackRock Fund Advisors boosted its stake in shares of Nanometrics by 3.6% in the second quarter. BlackRock Fund Advisors now owns 1,606,520 shares of the company’s stock worth $33,400,000 after buying an additional 55,176 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Nanometrics by 6.3% in the second quarter. Vanguard Group Inc. now owns 1,101,602 shares of the company’s stock worth $22,903,000 after buying an additional 64,835 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Nanometrics by 2.3% in the second quarter. Dimensional Fund Advisors LP now owns 888,974 shares of the company’s stock worth $18,481,000 after buying an additional 20,026 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Nanometrics by 2.5% in the second quarter. State Street Corp now owns 454,583 shares of the company’s stock worth $9,450,000 after buying an additional 10,944 shares in the last quarter. Hedge funds and other institutional investors own 82.25% of the company’s stock.